English | Español

Technology/Innovation
+ Technology/Innovation
Jamie Barrand | Mar 17, 2016

Allergan's dry eye disease therapy receives prior approval supplement from FDA
+ Technology/Innovation
Jamie Barrand | Mar 17, 2016

FDA panel deems Abbott's new dissolving stent safe, effective
+ Regulatory
Jamie Barrand | Mar 17, 2016

Health Leadership Council panel addresses Capitol Hill lawmakers
+ Regulatory
Kerry Goff | Mar 16, 2016

Obamacare subsidies causing increased tax woes for many
+ Regulatory
Jamie Barrand | Mar 15, 2016

Family physicians can play active role in end-of-life decisions
+ Technology/Innovation
Jamie Barrand | Mar 15, 2016

Sanofi, Merck to conclude joint European venture
+ Technology/Innovation
Jamie Barrand | Mar 15, 2016

Pfizer, American Diabetes Association team up for survey on diabetic nerve pain
+ Technology/Innovation
Jamie Barrand | Mar 15, 2016

Hemophilia treatment studied in recent Pfizer trial

Trending
+ Pharmaceuticals
Patient Daily | Aug 6, 2026

FDA approves Replimune’s melanoma drug Tudriqev after advisory committee debate
+ Pharmaceuticals
Patient Daily | Aug 4, 2026

Merck reports mixed results for tulisokibart in recent clinical trials and financial update
+ Regulatory
M. Y. Bailey | Aug 7, 2026

PhRMA's Zirkelbach: 340B program has changed dramatically with 'little transparency into how patients benefit'
Patient Daily reports | Aug 10, 2026

SoCal Breathe Free warns persistent sinus symptoms may signal chronic inflammation